Perfusion bioreactors culture cells over much longer periods, even months, by continuously feeding the cells with fresh media and removing spent media while keeping cells in culture. In perfusion there are different ways to keep the cells in culture while removing spent media.
The first kind need to mention is Mid-Scale (100Liters to 1,000 Liters), it hold a comparatively larger share in global market, which accounts for about 45.22% in 2018.
The following is Large Scale (>1,000 Liters) share 35.79% market share in 2018.And the rest remains to the Small Scale (?100 Liters) which is 18.99%.
From the view of region, North America have a larger market share in 2018 which account for 41.29% and will witness a stable growth in following years. Europe hold a market share of 22.51% will still play an important role which cannot be ignored.
According to this study, over the next five years the Perfusion Bioreactor market will register a 9.1% CAGR in terms of revenue, the global market size will reach US$ 820 million by 2024, from US$ 530 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Perfusion Bioreactor business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Perfusion Bioreactor market by product type, application, key manufacturers and key regions and countries.
This study considers the Perfusion Bioreactor value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Small Scale (?100 Liters)
Mid-Scale (100 Liters to 1,000 Liters)
Large Scale (>1,000 Liters)
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Biopharmaceutical
Biotechnology
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Sartorius AG
Thermo Fisher
GE Healthcare Life Sciences
Pall
Eppendorf AG
ZETA
3D Biotek
Infors HT
Applikon Biotechnology
Bioengineering AG
PBS Biotech, Inc.
Cell Culture Company
Zellwerk GmbH
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Perfusion Bioreactor consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Perfusion Bioreactor market by identifying its various subsegments.
Focuses on the key global Perfusion Bioreactor manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Perfusion Bioreactor with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Perfusion Bioreactor submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
